At AACR, a bold use of CAR-T raises hopes and provocative questions about its use in smoldering multiple myeloma.
Pfizer executive Andrew Baum, a former Citi analyst, has left his role as an executive vice president and chief strategy and ...
It’s a reasonable hope, given the results of that trial, which researchers presented at the American Association for Cancer ...
Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 ...
A leading animal rights group is accusing Pfizer of running afoul of its own standards in the handling of research monkeys.
In January, the Department of Labor proposed a rule that would mandate PBMs disclose a wide range of drug pricing information ...
On Saturday, with podcaster and psychedelics fan Joe Rogan standing over his shoulder, President Trump signed an executive ...
The research, published yesterday in Neuropsychopharmacology, used data from the NIH-supported Adolescent Brain Cognitive ...
Both narratives — that teen birth rates are too high or too low — problematize teen pregnancy and childbearing,” writes Riley ...
President Trump’s executive order on was largely applauded by advocates. But some also quietly worried the White House’s role ...
Hiya. Today, we see a proliferation of KRAS, as new data validate a once-undruggable space. Also, a double-edged push for PBM transparency, and the Breakthrough Prize was awarded to researchers for ...
State restrictions, Trump administration policies, and waning public support are further limiting adults' access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results